Akèy › Hidradénite suppurative › Massachusetts
Etid klinik pou Hidradénite suppurative nan Massachusetts
10 etid pou Hidradénite suppurative ap chèche patisipan nan sit nan Massachusetts.
Vil nan Massachusetts
Tèks ofisyèl etid la (Anglè)
Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
- Clinical Site 3, Boston
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07828860A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Beth Israel Deaconess Medical Center - Boston- Site Number : 8400001, Boston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07225569A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 104, Boston
Ap rekriteFaz 1
Laj 18 ak plis · Fanm · Mizajou Sep 18, 2026 · NCT06888193Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US030, Boston
- Investigative Site US048, Brighton
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06855498Targeting Nociceptors in Hidradenitis Suppurativa
- University of Massachusetts Chan Medical School, Worcester
Ap rekriteEtid obsèvasyon
Laj 18 a 75 · Tout sèks · Mizajou Sep 10, 2026 · NCT05403710Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Boston Childrens Hospital, Boston
Ap rekriteFaz 2
Laj 12 a 17 · Tout sèks · Mizajou Aug 6, 2026 · NCT07213973A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
- Beth Israel Deaconess Medical Center, Boston
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Jul 22, 2026 · NCT07384975The Safety and Efficacy of Roflumilast Foam in HS
- Beth Israel Deaconess Medical Center, Boston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2026 · NCT07263230A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- Tufts University, Boston
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
Ap rekriteEtid obsèvasyon
Laj 18 a 71 · Tout sèks · Mizajou Apr 16, 2026 · NCT07123038A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Beth Israel Deaconess Medical Center, Boston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 6, 2026 · NCT07244263Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.